Disease Info Card

Polymorphic Ventricular Tachycardia

Information about Polymorphic Ventricular Tachycardia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Polymorphic Ventricular Tachycardia

Most recent studies have shown that Polymorphic Ventricular Tachycardia shares some biological mechanisms with atrial-fibrillation, bradycardia, brugada-syndrome-(disorder), cardiac-arrest, cardiac-arrhythmia, cardiac-death, cardiac-fibrillation, cardiomyopathies, heart-diseases, heart-failure, long-qt-syndrome, premature-ventricular-contractions, sudden-cardiac-death, sudden-death, syncope, tachycardia-ventricular, torsades-de-pointes, ventricular-arrhythmia, ventricular-fibrillation, ventricular-tachycardia-catecholaminergic-polymorphic-1-(disorder).

Among the many pathways, these few ones have gauged particular interests from scientists studying Polymorphic Ventricular Tachycardia, and have been seen in publications frequently: Aging, Cardiac Conduction, Cardiac Muscle Contraction, Diuresis, Electron Transport, Electron Transport Chain, Glycosylation, Hyperphosphorylation, Innervation, Localization, Muscle Contraction, Oxidative Phosphorylation, Pathogenesis, Proteolysis, Response To Caffeine, Response To Camp, Skeletal Muscle Contraction, Swimming, Transport, Transposition

Quite a number of genes have been found to play important roles in Polymorphic Ventricular Tachycardia, such as CASQ2, FKBP1B, IGKV1-5, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR1, RYR2, SCN5A, SCTR, SNCG, TRDN, UBN1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.